BioLife Solutions, Inc. (BLFS)
37.19
+0.09
(+0.24%)
USD |
NASDAQ |
Aug 24, 16:00
37.22
+0.03
(+0.08%)
After-Hours: 20:00
BioLife Solutions EPS Diluted (Quarterly) : 0.915 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.915 |
| March 31, 2026 | 0.0241 |
| December 31, 2025 | 0.0152 |
| September 30, 2025 | 0.0127 |
| June 30, 2025 | -0.3314 |
| March 31, 2025 | -0.0095 |
| December 31, 2024 | 0.2556 |
| September 30, 2024 | -0.0369 |
| June 30, 2024 | -0.257 |
| March 31, 2024 | -0.225 |
| December 31, 2023 | -0.3337 |
| September 30, 2023 | -0.6686 |
| June 30, 2023 | -0.2348 |
| March 31, 2023 | -0.3187 |
| December 31, 2022 | -1.150 |
| September 30, 2022 | -0.2419 |
| June 30, 2022 | -1.716 |
| March 31, 2022 | -0.1766 |
| December 31, 2021 | -0.3554 |
| September 30, 2021 | 0.0018 |
| June 30, 2021 | 0.1898 |
| March 31, 2021 | -0.0336 |
| December 31, 2020 | -0.0712 |
| September 30, 2020 | -0.0358 |
| June 30, 2020 | -0.7032 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.062 |
| December 31, 2019 | -0.5937 |
| September 30, 2019 | 0.3497 |
| June 30, 2019 | 0.0222 |
| March 31, 2019 | -1.028 |
| December 31, 2018 | 0.0351 |
| September 30, 2018 | 0.0487 |
| June 30, 2018 | 0.05 |
| March 31, 2018 | -0.01 |
| December 31, 2017 | -0.05 |
| September 30, 2017 | -0.03 |
| June 30, 2017 | -0.06 |
| March 31, 2017 | -0.07 |
| December 31, 2016 | -0.26 |
| September 30, 2016 | -0.08 |
| June 30, 2016 | -0.11 |
| March 31, 2016 | -0.10 |
| December 31, 2015 | -0.09 |
| September 30, 2015 | -0.09 |
| June 30, 2015 | -0.08 |
| March 31, 2015 | -0.09 |
| December 31, 2014 | -0.08 |
| September 30, 2014 | -0.07 |
| June 30, 2014 | -0.07 |
| March 31, 2014 | -0.10 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.0884 |
| Agilent Technologies, Inc. | 1.198 |
| Danaher Corp. | 1.230 |
| Thermo Fisher Scientific, Inc. | 4.679 |
| West Pharmaceutical Services, Inc. | 2.160 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 45.10M |
| Revenue (Quarterly) | 28.47M |
| Total Expenses (Quarterly) | -16.64M |
| Enterprise Value | 1.752B |
| Gross Profit Margin (Quarterly) | 63.69% |
| Earnings Yield | 2.60% |
| Operating Earnings Yield | 0.16% |
| Normalized Earnings Yield | 2.600 |